Barba-Rosado LV, Carrascal-Hernández DC, Insuasty D, Grande-Tovar CD (2024) Graphene Oxide (GO) for the treatment of Bone Cancer: a systematic review and bibliometric analysis. Nanomaterials (Basel) 14(2):186. https://doi.org/10.3390/nano14020186
Article CAS PubMed Google Scholar
Boulares AH, Yakovlev AG, Ivanova V, Stoica BA, Wang G, Iyer S, Smulson M (1999) Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J Biol Chem 274(33):22932–22940. https://doi.org/10.1074/jbc.274.33.22932
Article CAS PubMed Google Scholar
Buddingh EP, Kuijjer ML, Duim RA, Bürger H, Agelopoulos K, Myklebost O, Serra M, Mertens F, Hogendoorn PC, Lankester AC, Cleton-Jansen AM (2011) Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents. Clin Cancer Res 17(8):2110–2119. https://doi.org/10.1158/1078-0432.CCR-10-2047
Article CAS PubMed Google Scholar
Chen C, Song M (2019) Visualizing a field of research: a methodology of systematic scientometric reviews. PLoS ONE 14(10):e0223994. https://doi.org/10.1371/journal.pone.0223994
Article CAS PubMed PubMed Central Google Scholar
Chen X, Bahrami A, Pappo A, Easton J, Dalton J, Hedlund E, Ellison D, Shurtleff S, Wu G, Wei L, Parker M, Rusch M, Nagahawatte P, Wu J, Mao S, Boggs K, Mulder H, Yergeau D, Lu C, Ding L, Edmonson M, Qu C, Wang J, Li Y, Navid F, Daw NC, Mardis ER, Wilson RK, Downing JR, Zhang J, Dyer MA; St. Jude Children’s Research Hospital–Washington University Pediatric Cancer Genome Project (2014) Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. Cell Rep 7(1):104–112. https://doi.org/10.1016/j.celrep.2014.03.003
Article CAS PubMed PubMed Central Google Scholar
Chen Z, Guo J, Zhang K, Guo Y (2016) TP53 mutations and survival in Osteosarcoma patients: a Meta-analysis of published data. Dis Markers 2016(4639575). https://doi.org/10.1155/2016/4639575
Chen L, He L, Liu B, Zhou Y, Lv L, Wang Z (2024) Intelligent structure prediction and visualization analysis of non-coding RNA in osteosarcoma research. Front Oncol 14:1255061. https://doi.org/10.3389/fonc.2024.1255061
Article CAS PubMed PubMed Central Google Scholar
Donthu N, Kumar S, Mukherjee D, Pandey N, Lim WM (2021) How to conduct a bibliometric analysis: an overview and guidelines. J Bus Res 133:285–296. https://doi.org/10.1016/j.jbusres.2021.04.070
Esperança-Martins M, Fernandes I, Soares do Brito J, Macedo D, Vasques H, Serafim T, Costa L, Dias S (2021) Sarcoma metabolomics: current Horizons and Future perspectives. Cells 10(6):1432. https://doi.org/10.3390/cells10061432
Article CAS PubMed PubMed Central Google Scholar
Fidler IJ (2003) The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 3(6):453–458. https://doi.org/10.1038/nrc1098
Article CAS PubMed Google Scholar
Fuloria S, Yadav G, Menon SV, Ali H, Pant K, Kaur M, Deorari M, Sekar M, Narain K, Kumar S, Fuloria NK (2024) Targeting the Wnt/beta-catenin cascade in osteosarcoma: the potential of ncRNAs as biomarkers and therapeutics. Pathol Res Pract 259:155346. https://doi.org/10.1016/j.prp.2024.155346
Article CAS PubMed Google Scholar
Gianferante DM, Mirabello L, Savage SA (2017) Germline and somatic genetics of osteosarcoma-connecting aetiology, biology and therapy. Nat Rev Endocrinol 13(8):480–491. https://doi.org/10.1038/nrendo.2017.16
Article CAS PubMed Google Scholar
Jeong E, Yoon S (2023) Current advances in comprehensive omics data mining for oncology and cancer research. Biochim Biophys Acta Rev Cancer 1879(1):189030. https://doi.org/10.1016/j.bbcan.2023.189030
Article CAS PubMed Google Scholar
Kansara M, Teng MW, Smyth MJ, Thomas DM (2014) Translational biology of osteosarcoma. Nat Rev Cancer 14(11):722–735. https://doi.org/10.1038/nrc3838
Article CAS PubMed Google Scholar
Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM, Helman LJ (2004) The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 10(2):182–186. https://doi.org/10.1038/nm982
Article CAS PubMed Google Scholar
Kovac M, Blattmann C, Ribi S, Smida J, Mueller NS, Engert F, Castro-Giner F, Weischenfeldt J, Kovacova M, Krieg A, Andreou D, Tunn PU, Dürr HR, Rechl H, Schaser KD, Melcher I, Burdach S, Kulozik A, Specht K, Heinimann K, Fulda S, Bielack S, Jundt G, Tomlinson I, Korbel JO, Nathrath M, Baumhoer D (2015) Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency. Nat Commun 6:8940. https://doi.org/10.1038/ncomms9940
Article CAS PubMed Google Scholar
Lee D, Kim S (2022) Knowledge-guided artificial intelligence technologies for decoding complex multiomics interactions in cells. Clin Exp Pediatr 65(5):239–249. https://doi.org/10.3345/cep.2021.01438
Article CAS PubMed Google Scholar
Liao D, Zhong L, Yin J, Zeng C, Wang X, Huang X, Chen J, Zhang H, Zhang R, Guan XY, Shuai X, Sui J, Gao S, Deng W, Zeng YX, Shen JN, Chen J, Kang T (2020) Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma. Nat Cell Biol 22(7):868–881. https://doi.org/10.1038/s41556-020-0522-z
Article CAS PubMed Google Scholar
Lindsey BA, Markel JE, Kleinerman ES (2017) Osteosarcoma Overview. Rheumatol Ther 4(1):25–43. https://doi.org/10.1007/s40744-016-0050-2
Liu Q, Huang J, Zhou N, Zhang Z, Zhang A, Lu Z, Wu F, Mo YY (2013) LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res 41(9):4976–4987. https://doi.org/10.1093/nar/gkt182
Article CAS PubMed PubMed Central Google Scholar
Ma X, Liu Y, Liu Y, Alexandrov LB, Edmonson MN, Gawad C, Zhou X, Li Y, Rusch MC, Easton J, Huether R, Gonzalez-Pena V, Wilkinson MR, Hermida LC, Davis S, Sioson E, Pounds S, Cao X, Ries RE, Wang Z, Chen X, Dong L, Diskin SJ, Smith MA, Guidry Auvil JM, Meltzer PS, Lau CC, Perlman EJ, Maris JM, Meshinchi S, Hunger SP, Gerhard DS, Zhang J (2018) Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours. Nature 555(7696):371–376. https://doi.org/10.1038/nature25795
Article CAS PubMed PubMed Central Google Scholar
Meltzer PS, Helman LJ (2021) New Horizons in the Treatment of Osteosarcoma. N Engl J Med 385(22):2066–2076. https://www.nejm.org/doi/10.1056/NEJMra2103423
Article CAS PubMed Google Scholar
Pan D, Jia D (2021) Application of single-cell multi-omics in dissecting Cancer Cell plasticity and Tumor Heterogeneity. Front Mol Biosci 8:757024. https://doi.org/10.3389/fmolb.2021.757024
Article CAS PubMed PubMed Central Google Scholar
Pei Y, Guo Y, Wang W, Wang B, Zeng F, Shi Q, Xu J, Guo L, Ding C, Xie X, Ren T, Guo W (2024) Extracellular vesicles as a new frontier of diagnostic biomarkers in osteosarcoma diseases: a bibliometric and visualized study. Front Oncol 14:1359807. https://doi.org/10.3389/fonc.2024.1359807
Article CAS PubMed PubMed Central Google Scholar
Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M (2007) TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 26(15):2157–2165. https://doi.org/10.1038/sj.onc.1210302
Article CAS PubMed Google Scholar
Pierron G, Tirode F, Lucchesi C, Reynaud S, Ballet S, Cohen-Gogo S, Perrin V, Coindre JM, Delattre O (2012) A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion. Nat Genet 44(4):461–466. https://doi.org/10.1038/ng.1107
Article CAS PubMed Google Scholar
Qiu Y, Yang W, Wang Q, Yan S, Li B, Zhai X (2018) Osteoporosis in postmenopausal women in this decade: a bibliometric assessment of current research and future hotspots. Arch Osteoporos 13(1):121.
Comments (0)